Short Interest in 111, Inc. Sponsored ADR (NASDAQ:YI) Declines By 57.5%

111, Inc. Sponsored ADR (NASDAQ:YI) saw a large decline in short interest in the month of May. As of May 29th, there was short interest totaling 6,011 shares, a decline of 57.5% from the May 14th total of 14,127 shares. Based on an average daily trading volume, of 21,907 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.1% of the company’s shares are short sold.

Insider Activity at 111

In other news, Director Jian David Sun sold 111,100 shares of 111 stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $0.23, for a total transaction of $25,553.00. Following the completion of the sale, the director owned 472,011 shares in the company, valued at $108,562.53. The trade was a 19.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 442,820 shares of company stock worth $105,980. 43.90% of the stock is owned by insiders.

111 Stock Up 14.3%

NASDAQ YI traded up $0.61 during trading on Friday, reaching $4.89. 63,632 shares of the stock traded hands, compared to its average volume of 26,072. The firm has a market cap of $42.98 million, a price-to-earnings ratio of -3.49 and a beta of 0.60. The stock’s 50-day moving average price is $5.92 and its 200 day moving average price is $5.64. 111 has a fifty-two week low of $2.48 and a fifty-two week high of $11.17.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.